Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.777
Filter
1.
J. Oral Diagn ; 9: e259, Jul. 2024. tab, ilus
Article in English | LILACS, BBO | ID: biblio-1584913

ABSTRACT

Objective: To evaluate the clinicopathological and immunohistochemical features of an original series of canalicular adenoma. Methods: Cases diagnosed as canalicular adenoma from a single center were retrospectively retrieved and clinical data collected from patients' charts. The histopathological features of all cases were reviewed and a large immunohistochemical panel carried out. Results: Eleven cases were collected, and no gender predilection was seen. A painless upper lip nodule was the most frequent clinical presentation. All cases presented the single-layer epithelial arrangement of tumor cells in a loose stroma. It was found an increased expression of low-weight cytokeratins, absence of myogenic markers, variable positivity for vimentin, S100 and GFAP, cytoplasmic and membrane reactivity for ß-catenin and a strong CD34 positivity, whereas no lymphatic vessel was identified using D2-40 antibody. Conclusion: Canalicular adenoma is composed of luminal epithelium with strong expression of low-weight cytokeratins, and peripheral expression of ß-catenin may be involved in the architectural maintenance of the tumor. (AU)


Subject(s)
Humans , Pathology, Clinical , Immunohistochemistry , Adenoma , Salivary Glands , Neoplasms
2.
Acta Medica Philippina ; : 1-12, 2024.
Article in English | WPRIM | ID: wpr-1011312

ABSTRACT

Background and Objective@#Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the fourth leading cause of cancer mortality worldwide. Likewise in the Philippines, the prevalence of CRC has shown to be increasing. Colonoscopy, a screening procedure for CRC, has parameters to gauge quality of detection. One of which is the Adenoma Detection Rate (ADR). Higher ADR has been linked to improved cancer detection. This study aimed to determine the ADR and Polyp Detection Rate (PDR) among Gastroenterology practitioners in a tertiary government university hospital in the Philippines, estimate ADR from PDR, and identify factors associated with ADR.@*Methods@#An analytical, cross-sectional study among patients who underwent colonoscopy for the years 2021 and the first half of 2022 at the Central Endoscopy Unit (CENDU) of the Philippine General Hospital. Demographic data of fellows and consultants were collected through an online form, while those from patients were obtained from electronic records. Colonoscopy details and histopathology results were accessed through the hospital’s Open Medical Record System (MRS). ADR, PDR, and estimated ADR were computed using established formulas. To evaluate the strength of the relationship between the estimated and actual ADR, Pearson’s correlation coefficient was used. Chi-square analysis, Mann-Whitney U test, and Kruskal-Wallis H test were performed to identify the factors that might influence the ADR. A cut-off of p < 0.05 was considered statistically significant.@*Results@#The total computed ADR of consultants and fellows combined is 22%. The difference between the ADRs of Gastroenterology consultants and Fellows-in-Training is statistically significant at 31.6% and 18.7%, respectively (p= 0.017). The total Polyp Detection Rate is 57.6% while the weighted group average Adenoma to Polyp Detection Rate Quotient (APDRQ) is 0.4085 or 40.85%. The estimated ADR has a moderate degree of correlation with the actual ADR when an outlier was excluded (r=0.521 (95% CI, 0.072-0.795, p=0.0266). Significant factors related to ADR include endoscopists’ years of practice (p=0.020), number of colonoscopies done (p=0.031), and patient tobacco use (p=0.014).@*Conclusion@#The overall ADR among consultants and fellows is at par with the standard guidelines. A moderate degree of correlation exists between actual and estimated ADR when an outlier is excluded; however, more studies are needed to determine the APDRQ in the wider local setting. Longer years in practice, total number of colonoscopies performed, and patient tobacco use are associated with increased ADR.


Subject(s)
Adenoma , Colonic Polyps , Colorectal Neoplasms , Colonoscopy
3.
Rev. argent. neurocir ; 38(1): 7-13, 2024. ilus
Article in Spanish | LILACS, BINACIS | ID: biblio-1585996

ABSTRACT

Introducción. El análisis de las técnicas y tipos de materiales a utilizar durante una reparación selar es fundamental para lograr una tasa de morbimortalidad aceptable. Objetivo. Realizar un análisis de los principales factores involucrados en la producción de una fístula de líquido cefalorraquídeo (LCR) durante la resección de un adenoma hipofisario y describir una serie de pautas a considerar en la selección del material más adecuado para la reparación selar. Materiales y Métodos. Se realizó una revisión retrospectiva de pacientes operados de adenoma de hipófisis por vía endonasal endoscópica, durante un período de 2 años, en la División Neurocirugía del Hospital de Clínicas "José de San Martín", de la Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina. Se registraron los materiales utilizados con su respectiva técnica reconstructiva y las complicaciones observadas. Los resultados obtenidos fueron comparados mediante una revisión bibliográfica. Resultados. Entre los 19 casos operados, un 67 % correspondió a macroadenomas y un 37 % a microadenomas. En todos los casos, se realizó una reconstrucción multicapa, utilizando materiales sintéticos y autólogos. Se registraron complicaciones en 2 casos, donde el cierre fue con técnica bicapa. Consistieron en fístula de LCR y, en uno de ellos, se generó adicionalmente neumoencéfalo. Ambos casos fueron resueltos por vía quirúrgica mediante una técnica reconstructiva multicapa. Conclusiones. El factor decisivo más importante para prevenir una fístula de LCR es la utilización de una técnica multicapa, independientemente de los materiales utilizados. Existe una tendencia a una mayor utilización de materiales sintéticos, pretendiendo evitar incisiones adicionales y teniendo en cuenta que se presentan con una biocompatibilidad similar a la de los materiales autólogos(AU)


Background. Endoscopic approaches to the cranial base have presented several limitations during the selar reparation. An analysis of techniques and materials that are used is essential to get an acceptable morbidity and mortality rate. Objectives. To carry out an analysis of the main factors which are present in the production of cerebrospinal fluid leak during the resection of pituitary adenomas and to set parameters we consider are important in the decision of which materials are appropriate to use for selar reparation. Methods. The authors did a quantitative retrospective review of patients operated of pituitary adenomas, considering micro and macroadenomas, removed by endoscopic endonasal approach, for 2 years, in the Neurosurgery Division, Hospital de Clínicas "José de San Martín", Buenos Aires University, Buenos Aires City, Argentina. The materials were registered during their use with the respective intrasurgical reconstructive technique and the complications that appeared. Through a bibliographic review we compared our results with other centers. Results. Of 19 cases that were operated, 67% were macroadenomas (more than 1 cm) and 37% were microadenomas (less than 1 centimeter). In all the cases, we did a multilayer reconstruction, using synthetic and autologist materials. Between these patients, we registered 2 complications that were operated at first time by the bilayer technique. Both patients presented cerebrospinal leak in the postoperative stage. One of those presented additionally pneumoencephalus. Both patients were treated with surgery using a multilayer technique, considering which materials are better to seal and which are better to be containers. Conclusion. The most important factor to prevent a cerebrospinal fluid leak is the use of the correct multilayer technique, regardless the material that are used, synthetic or autologic, considering which are better as sealants and which as containers(AU)


Subject(s)
Adenoma , Pituitary Gland , Fistula , Cerebrospinal Fluid Leak , Neurosurgery
4.
Gastroenterol. latinoam ; 35(1): 4-9, 2024. tab, ilus
Article in Spanish | LILACS | ID: biblio-1567405

ABSTRACT

Background: Underwater endoscopic mucosal resection (UEMR) emerges as a less complex alternative to endos- copic submucosal resection (ESD) for the treatment of colorectal lesions. We present two clinical cases of complex colon adenomas resolved using UEMR technique. Case 1: A 56-years-old male patient with an adenoma identified at the splenic flexure, detected during a screening colonoscopy, whose biopsy revealed low-grade dysplasia. A flat elevated lesion of approximately 30 mm is identified, with a mixed granular lateral spread (LST-GM) and a centra- lly elevated area as the dominant nodule (0-IIa+Is), without signs of deep invasion. UEMR is performed, achieving a complete block resection. Case 2: A 62-year-old female patient referred for endoscopic resection of a complex adenoma in the transverse colon. A type 0-IIa lesion is observed with a smooth convergence of folds towards its periphery, approximately 15 mm in size, and a non-categorical crypt pattern of submucosal invasion. Insufflation and peristalsis tests did not show categorical elements of deep invasion. Resection is performed in sections using the UEMR technique, without complications. Conclusion: UEMR appears as a more effective alternative than conventional endoscopic mucosal resection (CEMR) and simpler and more accessible than ESD for the resection of colon adenomas larger than 20 mm, supported by controlled clinical studies. However, a more in-depth eva- luation of its scope, effectiveness, and safety is still required to establish its role in regular endoscopic practice.


Introducción: La mucosectomía endoscópica bajo agua (UEMR) surge como una alternativa menos compleja que la resección endoscópica submucosa (ESD) para el tratamiento de lesiones colorrectales. Presentamos a continua- ción dos casos clínicos de adenomas complejos de colon resueltos mediante la técnica UEMR. Caso 1: Paciente masculino de 56 años con un hallazgo de adenoma a nivel del ángulo esplénico, detectado en colonoscopía de tamizaje, cuya biopsia evidenció una displasia de bajo grado. Se identifica una lesión plana elevada de aproxi- madamente 30 mm, de extensión lateral granular mixta (LST-GM) con área central solevantada como nódulo dominante (0-IIa+Is), sin signos de invasión profunda. Se realiza una UEMR logrando una resección en bloque. Caso 2: Paciente femenina de 62 años, referida para resección endoscópica de un adenoma complejo de colon transverso. Se observó lesión tipo 0-IIa con confluencia suave de pliegues hacia su periferia de aproximadamente 15 mm con patrón de criptas no categórico de invasión submucosa. Las pruebas de insuflación y peristaltismo no evidenciaron elementos categóricos de invasión profunda. Se realiza resección por parcialidades con técnica de UEMR, sin complicaciones. Conclusión: La UEMR se presenta como una alternativa más efectiva que la CEMR y más simple y accesible que la ESD para la resección de adenomas de colon mayores de 20 mm, respaldada por estudios clínicos controlados. Sin embargo, aún se requiere una evaluación más profunda de sus alcances, efecti- vidad y seguridad, para establecer su papel en la práctica endoscópica regular.


Subject(s)
Humans , Male , Female , Middle Aged , Colorectal Neoplasms/surgery , Adenoma/surgery , Endoscopic Mucosal Resection/methods , Immersion
5.
Gastroenterol. latinoam ; 35(2): 56-63, 2024. ilus
Article in Spanish | LILACS | ID: biblio-1568193

ABSTRACT

Adenoma detection rate (ADR) is a key quality indicator in screening colonoscopy, closely linked to colorectal cancer (CRC) prevention. Currently, the minimum recommended ADR is > 30% with an aspirational goal of > 35%; and the sessile serrated lesion detection rate (SSLDR) minimum is > 7% with an aspirational goal of > 10%. Improving the detection of adenomas and serrated lesions involves rigorous bowel preparation, using the validated Boston Bowel Preparation Scale (BBPS) with an adequate or superior score (≥ 6, with each segment ≥ 2: right-transverse-left) (minimum > 90% and > 95% aspirational goal). The most basic strategy is to implement split-dose bowel preparation regimens. A minimum withdrawal time of 6 minutes, ideally extended to 9 minutes, improves ADR and SSLDR, especially in the proximal colon. Incorporating techniques such as double examination of the right colon (retroflexion or second forward view), water-assisted colonoscopy, enhanced imaging endoscopy technologies (e.g., NBI, TXI, LCI, BLI), distal attachment devices, artificial intelligence systems (CADe), along with monitoring, feedback, continuing education, and teamwork, are key strategies to increase ADR and SSLDR, consequently, reduce the risk of post-colonoscopy or interval CRC.


La tasa de detección de adenomas (ADR) es un indicador de calidad fundamental en la colonoscopia de tamizaje, estrechamente relacionado con la prevención del cáncer colorrectal (CCR). Actualmente la ADR mínima reco- mendada es > 30% y aspiracional > 35%; y la tasa de detección de lesiones serradas sésiles (SSLDR) mínima > 7% y aspiracional > 10%. Mejorar la detección de adenomas y pólipos serrados implica una preparación intestinal rigurosa, utilizando la escala validada de Boston con puntuación adecuada o superior (≥ 6, con cada segmento ≥ 2: derecho-transverso-izquierdo) (mínimo > 90% y > 95% meta aspiracional). Siendo la estrategia más básica implementar regímenes de preparación intestinal en dosis divididas. Un tiempo de retirada mínimo de 6 minutos, idealmente extendido a 9 minutos, mejora la ADR y SSLDR, especialmente en el colon proximal. La incorporación de técnicas como la doble inspección del colon derecho (retroflexión o segunda visión frontal), la colonoscopia asistida por agua, tecnologías de endoscopia con imagen mejorada (ej: NBI, TXI, LCI, BLI), dispositivos de fija- ción distal, sistemas de inteligencia artificial (CADe), junto con la monitorización, retroalimentación, educación continua y trabajo en equipo, son estrategias clave para aumentar la ADR y SSLDR, en consecuencia, reducir el riesgo de CCR posterior de colonoscopia o intervalo.


Subject(s)
Humans , Colorectal Neoplasms/diagnosis , Adenoma/diagnosis , Colonic Polyps/diagnosis , Colonoscopy/methods , Artificial Intelligence , Colorectal Neoplasms/prevention & control , Adenoma/prevention & control , Colonic Polyps/prevention & control , Early Diagnosis
6.
Cambios rev. méd ; 22 (2), 2023;22(2): 927, 16 octubre 2023. ilus, tabs
Article in Spanish | LILACS | ID: biblio-1516527

ABSTRACT

El hipertiroidismo es un trastorno caracterizado por el exceso de hormonas tiroideas. El déficit de yodo es un factor clave en dicha patología y en lugares con suficiencia del mismo se asocian a au-toinmunidad tiroidea. La prevalencia de hipertiroidismo mani-fiesto varía del 0,2% al 1,3% en áreas con suficiencia de yodo, sin embargo, esto puede variar en cada país por diferencias en umbrales de diagnóstico, sensibilidad de ensayo y población se-leccionada. Un reporte de The Third National Health and Nutri-tion Examination Survey (NHANES III) mostró que el hiperti-roidismo manifiesto se presenta en 0,7% de la población general e hipertiroidismo subclínico en el 1,7%1,2.En incidencia, la patología se asocia con la suplementación de yodo, con la mayor frecuencia en áreas de deficiencias, por au-mento de nódulos tiroideos en la población anciana, teniendo a regiones de áreas montañosas como América del Sur, África Central y suroeste de Asia dentro de este grupo. Un meta aná-lisis de estudios europeos mostró una incidencia general de 50 casos por 100000 personas/años1. En Ecuador, según los datos del Instituto Nacional de Estadísticas y Censos (INEC) del 2017, se reportaron 157 casos de hipertiroidismo, de los cuales la En-fermedad de Graves (EG) fue la causa más común, seguida por el bocio multinodular tóxico (BMNT) y finalmente el adenoma tóxico (AT) con una incidencia de 61 %, 24 % y 14 % respecti-vamente3.Los pacientes con esta patología tienen aumento de riesgo com-plicaciones cardiovasculares y mortalidad por todas las causas, siendo falla cardíaca uno de sus principales desenlaces, así el diagnóstico precoz evita estos eventos, principalmente en pobla-ción de edad avanzada.El presente protocolo se ha realizado para un correcto trata-miento de esta patología en el Hospital de Especialidades Carlos Andrade Marín (HECAM).


Hyperthyroidism is a disorder characterized by an excess of thyroid hormones. Iodine deficiency is a key factor in this pa-thology and in places with iodine deficiency it is associated with thyroid autoimmunity. The prevalence of overt hyperthyroidism varies from 0,2% to 1,3% in iodine-sufficient areas; however, this may vary from country to country due to differences in diag-nostic thresholds, assay sensitivity, and selected population. A report from The Third National Health and Nutrition Examina-tion Survey (NHANES III) showed that overt hyperthyroidism occurs in 0,7% of the general population and subclinical hyper-thyroidism in 1,7%1,2.In incidence, the pathology is associated with iodine supplemen-tation, with the highest frequency in areas of deficiencies, due to increased thyroid nodules in the elderly population, having regions of mountainous areas such as South America, Central Africa and Southwest Asia within this group. A meta-analysis of European studies showed an overall incidence of 50 cases per 100000 person/years1. In Ecuador, according to data from the National Institute of Statistics and Census (INEC) in 2017, 157 cases of hyperthyroidism were reported, of which, Graves' di-sease (GD) was the most common cause, followed by toxic mul-tinodular goiter (BMNT) and finally toxic adenoma (TA) with an incidence of 61 %, 24 % and 14 % respectively3.Patients with this pathology have an increased risk of cardiovas-cular complications and all-cause mortality, with heart failure being one of the main outcomes, so early diagnosis avoids these events, mainly in the elderly population.The present protocol has been carried out for the correct treat-ment of this pathology at the Carlos Andrade Marín Specialties Hospital (HECAM).


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Antithyroid Agents , Thyroid Hormones , Graves Disease , Endocrinology , Graves Ophthalmopathy , Hyperthyroidism , Thyroid Diseases , Thyroid Gland , Iodine Deficiency , Thyroid Crisis , Adenoma , Ecuador , Goiter, Nodular
7.
Rev. argent. neurocir ; 37(3): 134-143, sept. 2023. ilus
Article in Spanish | LILACS, BINACIS | ID: biblio-1572498

ABSTRACT

Introducción: los prolactinomas son los adenomas hipofisarios funcionantes más frecuentes y la primera opción de tratamiento es la farmacológica en la mayoría de los casos. La cirugía está indicada en pacientes con resistencia o con intolerancia a los Agonistas Dopaminérgicos (AD). Objetivos: evaluar las características clínicas, bioquímicas y por imágenes de un grupo de pacientes con prolactinomas que requirieron Cirugía Endoscópica Endonasal (CEE) y analizar los resultados quirúrgicos. Material y métodos: se analizaron en forma retrospectiva las historias clínicas de 17 pacientes (8 mujeres /9 varones) con diagnóstico de prolactinoma pertenecientes a dos hospitales de la ciudad de Buenos Aires, los cuales fueron intervenidos quirúrgicamente en el periodo comprendido entre enero de 2011 y junio de 2021. Se analizaron las indicaciones de la cirugía y los resultados quirúrgicos obtenidos, y se realizó una revisión de la literatura referente al tema. Resultados: Las indicaciones para la cirugía en los 17 pacientes fueron: 8 resistencia a los AD, 2 intolerancia a los AD, 2 apoplejía tumoral, 2 fístula de líquido cefalorraquídeo (LCR), 1 adenoma quístico, 1 compromiso visual severo y 1 macroadenoma por sospecha de adenoma no funcionante (ANF). Según el tamaño tumoral, se clasificaron en 16 macroadenomas (Ma), 5 de ellos > 4 cm o gigantes (G), y sólo una paciente con microadenoma (Mi) e intolerancia a los AD. Se logró la resección total en 8 pacientes, subtotal en 5 y parcial en 4. Se obtuvo la remisión bioquímica en 7 casos (41,2%) con cirugía (1 Mi /5 Ma/1 G) y los 10 restantes (6 Ma/4 G) requirieron terapia farmacológica y/o radioterapia (RT) adyuvante, de los cuales 5 se encuentran con enfermedad activa. Publicaciones recientes avalan el resurgimiento del tratamiento quirúrgico para este subtipo de adenomas, sobre todo en microadenomas, debido principalmente al perfeccionamiento de la técnica quirúrgica, que permitió obtener mejores resultados postoperatorios en relación a la remisión bioquímica y menor tasa de complicaciones. Conclusión.La CEE permite una alta tasa de curación en microprolactinomas y macroprolactinomas no invasores debiendo ser considerada como una opción viable y concreta durante la evaluación multidisciplinaria de estos pacientes(AU)


Background: prolactinomas are the most frequent functioning pituitary adenomas and the first treatment option is pharmacological in most of them. Surgery is indicated in patients with resistance or intolerance to Dopaminergic Agonists (DA). Objectives: to evaluate the clinical, biochemical and imaging characteristics of a group of patients with prolactinomas who required Endonasal Endoscopic Surgery (EES) and to analyze the surgical results. Methods: the medical records of 17 patients (8 women / 9 men) diagnosed with prolactinoma belonging to two hospitals in the city of Buenos Aires, who underwent surgery in the period from January 2011 and June 2021. The indications for surgery and the surgical results obtained were analyzed, and a review of the literature on the subject was carried out. Results: The indications for surgery in the 17 patients were: 8 DA resistance, 2 DA intolerance, 2 tumor apoplexy, 2 cerebrospinal fluid (CSF) fistula, 1 cystic adenoma, 1 severe visual impairment, and 1 macroadenoma due to suspected non-functional adenoma (NFA). According to tumor size, they were classified into 16 macroadenomas (Ma), 5 of them > 4 cm or giant (G), and only one patient with microadenoma (Mi) and intolerance to AD. Total resection was obtained in 8, subtotal in 5 and partial in 4 patients. Biochemical remission was obtained in 7 cases (41.2%) with surgery (1 Mi/5 Ma/1Gi) and the remaining 10 (6 Ma/4 Gi) required drug therapy and/or adjuvant radiotherapy (RT), 5 of whom are with active disease. Recent publications support the resurgence of surgical treatment for this subtype of adenomas, especially in microadenomas, mainly due to the improvement of surgical techniques, which showed better postoperative results in relation to biochemical remission and a lower rate of complications. Conclusion: EESallows a high cure rate in microprolactinomas and in non-invasive macroprolactinomas, and should be considered as a viable and concrete therapeutic option during the multidisciplinary evaluation of these patients(AU)


Subject(s)
Endoscopy , General Surgery , Prolactinoma , Adenoma , Dopamine Agonists
8.
Rev. Hosp. Ital. B. Aires (2004) ; 43(2): 79-84, jun. 2023. ilus
Article in Spanish | LILACS, UNISALUD, BINACIS | ID: biblio-1510716

ABSTRACT

Introducción: desde el punto de vista anatómico, los adenomas hipofisarios (AH) se observan en el 10% de la población. Son en su mayoría pequeños y no funcionantes. La mayoría de los incidentalomas descubiertos en estudios de imágenes con alta resolución pedidos en situaciones clínicas frecuentes, como el traumatismo craneoencefálico, el accidente cerebrovascular y las demencias, corresponden a AH indolentes. Nos preguntamos cuál es la relevancia clínica de los adenomas hipofisarios. Desarrollo: los AH clínicamente relevantes son tumores en su mayoría benignos que conllevan, en diferentes proporciones, aumento en la morbilidad y/o mortalidad de los pacientes por mecanismos relacionados con la hipersecreción hormonal, la insuficiencia hormonal y/o los efectos de masa ocupante. La prevalencia de los AH clínicamente relevantes es mayor de la que se suponía hace 20 años. Afecta aproximadamente a 1/1000 habitantes. Los más prevalentes son los prolactinomas y los adenomas no funcionantes. La acromegalia, la enfermedad de Cushing y los tumores agresivos se traducen en pacientes complejos con mayor morbimortalidad. El diagnóstico temprano y el tratamiento multimodal proveen una razonable mejoría de la sobrevida. El estudio epidemiológico de los AH clínicamente relevantes es importante para la estimación del impacto en los sistemas de salud. Conclusiones: los estudios por imágenes de mejor resolución continuarán señalando incidentalomas hipofisarios. Una evaluación cuidadosa de los pacientes podrá identificar aquellos AH clínicamente relevantes. (AU)


Introduction: from the anatomical point of view, pituitary adenomas (HA) are observed in 10% of the population. They are mostly small and non-functioning. Most incidentalomas discovered in high-resolution imaging studies ordered in frequent clinical situations, such as head trauma, stroke and dementia, correspond to indolent HA. We wonder what is the clinical relevance of pituitary adenomas. Development: clinically relevant HAs are mostly benign tumors that lead, in different degrees, to an increased morbidity and/or mortality in patients by mechanisms related to hormone hypersecretion, hormone insufficiency and/or occupying mass effects. The prevalence of clinically relevant HA is higher from what was assumed 20 years ago. It affects approximately 1/1000 of the population. The most prevalent are prolactinomas and non-functioning adenomas. Acromegaly, Cushing's disease and aggressive tumors make for complex patients with increased morbidity and mortality. Early diagnosis and multimodal treatment provide a reasonable improvement in survival. Epidemiological study of clinically relevant HAs is important for estimating the impact on health systems. Conclusions: Higher-resolution imaging studies will continue to highlight pituitary incidentalomas. Careful evaluation of patients will identify clinically relevant HAs. (AU)


Subject(s)
Humans , Male , Female , Adult , Young Adult , Pituitary Neoplasms/epidemiology , Acromegaly/epidemiology , Prolactinoma/epidemiology , Adenoma/epidemiology , Incidental Findings , Pituitary ACTH Hypersecretion/epidemiology , Pituitary Neoplasms/pathology , Pituitary Neoplasms/diagnostic imaging , Adenoma/pathology , Adenoma/diagnostic imaging , Clinical Relevance
9.
Chin. med. j ; Chin. med. j;(24): 159-166, 2023.
Article in English | WPRIM | ID: wpr-970030

ABSTRACT

BACKGROUND@#Colorectal cancer (CRC) screening is effective in reducing CRC incidence and mortality. The aim of this study was to retrospectively determine and compare the detection rate of adenomas, advanced adenomas (AAs) and CRCs, and the number needed to screen (NNS) of individuals in an average-risk Chinese population of different ages and genders.@*METHODS@#This was a retrospective study performed at the Institute of Health Management, Chinese People's Liberation Army General Hospital. Colonoscopy results were analyzed for 53,152 individuals finally enrolled from January 2013 to December 2019. The detection rate of adenomas, AAs, or CRCs was computed and the characteristics between men and women were compared using chi-squared test.@*RESULTS@#The average age was 48.8 years (standard deviation [SD], 8.5 years) for men and 50.0 years (SD, 9.0 years) for women, and the gender rate was 66.27% (35,226) vs . 33.73% (17,926). The detection rates of adenomas, AAs, serrated adenomas, and CRCs were 14.58% (7750), 3.09% (1641), 1.23% (653), and 0.59% (313), respectively. Men were statistically significantly associated with higher detection rates than women in adenomas (17.20% [6058/35,226], 95% confidence interval [CI] 16.74-17.53% vs . 9.44% [1692/17,926], 95% CI 8.94-9.79%, P  < 0.001), AAs (3.72% [1309], 95% CI 3.47-3.87% vs . 1.85% [332], 95% CI 1.61-2.00%, P  < 0.001), and serrated adenomas (1.56% [548], 95% CI 1.43-1.69% vs . 0.59% [105], 95% CI 0.47-0.70%, P  < 0.001). The detection rate of AAs in individuals aged 45 to 49 years was 3.17% (270/8510, 95% CI 2.80-3.55%) in men and 1.69% (69/4091, 95% CI 1.12-1.86%) in women, and their NNS was 31.55 (95% CI 28.17-35.71) in men and 67.11 (95% CI 53.76-89.29) in women. The NNS for AAs in men aged 45 to 49 years was close to that in women aged 65 to 69 years (29.07 [95% CI 21.05-46.73]).@*CONCLUSIONS@#The detection rates of adenomas, AAs, and serrated adenomas are high in the asymptomatic population undergoing a physical examination and are associated with gender and age. Our findings will provide important references for effective population-based CRC screening strategies in the future.


Subject(s)
Humans , Male , Female , Middle Aged , Retrospective Studies , Early Detection of Cancer , Colonoscopy/methods , Adenoma/epidemiology , Colorectal Neoplasms/epidemiology
10.
Zhonghua Bing Li Xue Za Zhi ; (12): 142-146, 2023.
Article in Chinese | WPRIM | ID: wpr-970148

ABSTRACT

Objective: To explore the feasibility and application value of intraoperative direct immunohistochemical (IHC) staining in improving the diagnosis accuracy in difficult cases of bronchiolar adenoma (BA). Methods: Nineteen cases with single or multiple pulmonary ground-glass nodules or solid nodules indicated by imaging in Cancer Hospital of Chinese Academy of Medical Sciences from January to July 2021 and with difficulty in differential diagnosis at frozen HE sections were selected. In the experimental group, direct IHC staining of cytokeratin 5/6 (CK5/6) and p63 was performed on frozen sections to assist the differentiation of BA from in situ/micro-invasive adenocarcinoma/adenocarcinoma/invasive mucinous adenocarcinoma. In the control group, two pathologists performed routine frozen HE section diagnosis on these 19 cases. The diagnostic results of paraffin sections were used as the gold standard. The sensitivity and specificity of BA diagnosis, consistency with paraffin diagnosis and time used for frozen diagnosis were compared between the experimental group and the control group. Results: The basal cells of BA were highlighted by CK5/6 and p63 staining. There were no basal cells in the in situ/microinvasive adenocarcinoma/adenocarcinoma/invasive mucinous adenocarcinoma. In the experimental group, the sensitivity and specificity with aid of direct IHC staining for BA were 100% and 86.7%, respectively, and the Kappa value of frozen and paraffin diagnosis was 0.732, and these were significantly higher than those in the control group (P<0.05). The average time consumption in the experimental group (32.4 min) was only 7 min longer than that in the control group (25.4 min). Conclusions: Direct IHC staining can improve the accuracy of BA diagnosis intraoperatively and reduce the risk of misdiagnosis, but require significantly longer time. Thus frozen direct IHC staining should be restricted to cases with difficulty in differentiating benign from malignant diseases, especially when the surgical modalities differ based on the frozen diagnosis.


Subject(s)
Humans , Paraffin , Sensitivity and Specificity , Adenocarcinoma in Situ , Adenoma/diagnosis , Adenocarcinoma, Mucinous/surgery , Frozen Sections/methods
11.
Chin. med. j ; Chin. med. j;(24): 788-798, 2023.
Article in English | WPRIM | ID: wpr-980870

ABSTRACT

BACKGROUND@#Many nutritional supplements and pharmacological agents have been reported to show preventive effects on colorectal adenoma and colorectal cancer (CRC). We performed a network meta-analysis to summarize such evidence and assess the efficacy and safety of these agents.@*METHODS@#We searched PubMed, Embase, and the Cochrane Library for studies published in English until October 31, 2021 that fit our inclusion criteria. We performed a systematic review and network meta-analysis to assess the comparative efficacy and safety of candidate agents (low-dose aspirin [Asp], high-dose Asp, cyclooxygenase-2 inhibitors [coxibs], calcium, vitamin D, folic acid, ursodeoxycholic acid [UDCA], estrogen, and progesterone, alone or in combination) for preventing colorectal adenoma and CRC. Cochrane risk-of-bias assessment tool was employed to evaluate the quality of each included study.@*RESULTS@#Thirty-two randomized controlled trials (278,694 participants) comparing 13 different interventions were included. Coxibs significantly reduced the risk of colorectal adenoma (risk ratio [RR]: 0.59, 95% confidence interval [CI]: 0.44-0.79, six trials involving 5486 participants), advanced adenoma (RR: 0.63, 95% CI: 0.43-0.92, four trials involving 4723 participants), and metachronous adenoma (RR: 0.58, 95% CI: 0.43-0.79, five trials involving 5258 participants) compared with placebo. Coxibs also significantly increased the risk of severe adverse events (RR: 1.29, 95% CI: 1.13-1.47, six trials involving 7109 participants). Other interventions, including Asp, folic acid, UDCA, vitamin D, and calcium, did not reduce the risk of colorectal adenoma in the general and high-risk populations compared with placebo.@*CONCLUSIONS@#Considering the balance between benefits and harms, regular use of coxibs for prevention of colorectal adenoma was not supported by the current evidence. Benefit of low-dose Asp for chemoprevention of colorectal adenoma still requires further evidence.@*REGISTRATION@#PROSPERO, No. CRD42022296376.


Subject(s)
Humans , Cyclooxygenase 2 Inhibitors , Calcium , Network Meta-Analysis , Vitamins , Colorectal Neoplasms/drug therapy , Chemoprevention , Aspirin , Adenoma/prevention & control , Vitamin D
12.
Zhonghua xinxueguanbing zazhi ; (12): 1152-1159, 2023.
Article in Chinese | WPRIM | ID: wpr-1046078

ABSTRACT

Objective: To explore the value of catheter-based adrenal ablation in treating Cushing's syndrome (CS)-associated hypertension. Methods: A clinical study was conducted in patients with CS, who received catheter-based adrenal ablation between March 2018 and July 2023 in Daping Hospital. Parameters monitored were blood pressure (outpatient and 24-hour ambulatory), body weight, clinical characteristics, serum cortisol and adrenocorticotropic hormone (ACTH) at 8 am, 24-hour urinary free cortisol (24 h UFC), fasting blood glucose and postoperative complications. Procedure effectiveness was defined as blood pressure returning to normal levels (systolic blood pressure<140 mmHg (1 mmHg=0.133 kPa) and diastolic blood pressure<90 mmHg), cortisol and 24 h UFC returning to normal and improvement of clinical characteristics. The parameters were monitored during follow up in the outpatient department at 1, 3, 6, and 12 months after catheter-based adrenal ablation. Results: A total of 12 patients (aged (40.0±13.2) years) were reviewed. There were 5 males, with 5 cases of adenoma and 7 with hyperplasia from imaging studies. Catheter-based adrenal ablation was successful in all without interruption or surgical conversion. No postoperative complication including bleeding, puncture site infection, adrenal artery rupture or adrenal bleeding was observed. The mean follow up was 28 months. Compared to baseline values, body weight declined to (59.48±11.65) kg from (64.81±10.75) kg (P=0.008), fasting blood glucose declined to (4.54±0.83) mmol from (5.53±0.99) mmol (P=0.044), outpatient systolic blood pressure declined to (128±21) mmHg from (140±19) mmHg (P=0.005), diastolic blood pressure declined to (78±10) mmHg from (86±11) mmHg (P=0.041), and the mean ambulatory daytime diastolic blood pressure declined to (79±12) mmHg from (89±8) mmHg (P=0.034). Catheter-based adrenal ablation in 8 patients was defined as effective with their 24 h UFC significantly reduced after the procedure (1 338.41±448.06) mmol/L from (633.66±315.94) mmol/L, P=0.011). The change of 24 h UFC between the effective treatment group and ineffective group was statistically significant (P=0.020). The postoperative systolic blood pressure in the treated adenoma group was significantly lower than those of hyperplasia group (112±13) mmHg vs. (139±20) mmHg, P=0.026). Conclusions: For patients with CS-associated hypertension who are unwilling or unable to undergo surgical treatment, catheter-based adrenal ablation could improve the blood pressure and cortisol level. Catheter-based adrenal ablation could be a safe, effective, and minimally invasive therapy. However, our results still need to be validated in further large-scale studies.


Subject(s)
Male , Humans , Cushing Syndrome/complications , Hydrocortisone , Adrenal Gland Neoplasms/surgery , Feasibility Studies , Blood Glucose , Hyperplasia/complications , Hypertension/complications , Adenoma/complications , Body Weight , Catheters/adverse effects
13.
Zhonghua zhong liu za zhi ; (12): 1041-1050, 2023.
Article in Chinese | WPRIM | ID: wpr-1046156

ABSTRACT

Objective: To evaluate the participation rate and detection of colorectal neoplasms based on annual fecal immunochemical testing (FIT) for three consecutive years in a population-based colorectal cancer screening program in China. Methods: Based on a population-based colorectal cancer screening program conducted from May 2018 to May 2021 in 6 centers in China, 7 793 eligible participants aged 50-74 were included and offered free FIT and colonoscopy (for those who were FIT-positive on initial screening). At baseline, all participants were invited to receive FIT. In subsequent screening rounds, only FIT-positive participants who did not undergo colonoscopy or FIT-negative participants were invited to have repeated FIT screening. FIT-positive participants were recommended to undertake colonoscopy and pathological examination (if abnormalities were found during colonoscopy). An overall of three rounds of annual FIT screening were conducted. The primary outcomes of the study were the participation rate of FIT screening, the compliance rate of colonoscopy for FIT-positive participants, and the detection rate of colorectal neoplasms. Results: Among the 7 793 participants included in this study, 3 310 (42.5%) were male, with age of (60.50±6.49) years. The overall participation rates for the first, second and third round of FIT screening were 94.0%(7 327/7 793), 86.8% (6 048/6 968) and 91.3% (6 113/6 693), respectively. Overall, 7 742 out of 7 793 participants (99.3%) attended at least one round of screening, and 5 163 out of 7 793 participants (66.3%) attended all three rounds of screening. The positivity rate was significantly higher in the first (14.6%, 1 071/7 327) round compared with the second (5.6%, 3 41/6 048) and third (5.5%, 3 39/6 113) screening rounds (P<0.001). The overall compliance rates of colonoscopy examination among FIT-positive subjects were over 70% in three rounds, which were 76.3% (817/1 071), 75.7% (258/341) and 71.7% (243/339), respectively. In a multivariate logistic regression model considering factors including sex, education background, smoking, alcohol drinking, previous colonoscopy examination, colonic polyp history and family history of colorectal cancer among first-degree relatives, gender and smoking status were related factors affecting the participation rate of FIT screening, with higher rate in males and non-smokers. In addition, logistic regression analysis also found that age was negatively correlated with the compliance rate of colonoscopy in FIT positive patients. The detection rate of advanced tumors (colorectal cancer + advanced adenoma) declined from the first round to subsequent rounds [1st round: 1.15% (90/7 793); 2nd round: 0.57% (40/6 968); and 3rd round: 0.58% (39/6 693)], however, the positive predictive value for advanced neoplasms increased round by round, and was 11.02% in the first screening round, 15.50% in the second screening round, and 16.05 % in the third screening round. In each screening round, the detection rate for advanced neoplasms was higher in men than that in women, and increased with age. Conclusions: Annual repeated FIT screening has high acceptance and satisfying detection rates in the Chinese population. To optimize and improve the effectiveness of colorectal cancer screening, multi-round repeated FIT screening should be implemented while ensuring high participation rates.


Subject(s)
Humans , Male , Female , Early Detection of Cancer , Predictive Value of Tests , Colonoscopy , Mass Screening , Adenoma/diagnosis , Colorectal Neoplasms/pathology
14.
Zhonghua xinxueguanbing zazhi ; (12): 1152-1159, 2023.
Article in Chinese | WPRIM | ID: wpr-1045755

ABSTRACT

Objective: To explore the value of catheter-based adrenal ablation in treating Cushing's syndrome (CS)-associated hypertension. Methods: A clinical study was conducted in patients with CS, who received catheter-based adrenal ablation between March 2018 and July 2023 in Daping Hospital. Parameters monitored were blood pressure (outpatient and 24-hour ambulatory), body weight, clinical characteristics, serum cortisol and adrenocorticotropic hormone (ACTH) at 8 am, 24-hour urinary free cortisol (24 h UFC), fasting blood glucose and postoperative complications. Procedure effectiveness was defined as blood pressure returning to normal levels (systolic blood pressure<140 mmHg (1 mmHg=0.133 kPa) and diastolic blood pressure<90 mmHg), cortisol and 24 h UFC returning to normal and improvement of clinical characteristics. The parameters were monitored during follow up in the outpatient department at 1, 3, 6, and 12 months after catheter-based adrenal ablation. Results: A total of 12 patients (aged (40.0±13.2) years) were reviewed. There were 5 males, with 5 cases of adenoma and 7 with hyperplasia from imaging studies. Catheter-based adrenal ablation was successful in all without interruption or surgical conversion. No postoperative complication including bleeding, puncture site infection, adrenal artery rupture or adrenal bleeding was observed. The mean follow up was 28 months. Compared to baseline values, body weight declined to (59.48±11.65) kg from (64.81±10.75) kg (P=0.008), fasting blood glucose declined to (4.54±0.83) mmol from (5.53±0.99) mmol (P=0.044), outpatient systolic blood pressure declined to (128±21) mmHg from (140±19) mmHg (P=0.005), diastolic blood pressure declined to (78±10) mmHg from (86±11) mmHg (P=0.041), and the mean ambulatory daytime diastolic blood pressure declined to (79±12) mmHg from (89±8) mmHg (P=0.034). Catheter-based adrenal ablation in 8 patients was defined as effective with their 24 h UFC significantly reduced after the procedure (1 338.41±448.06) mmol/L from (633.66±315.94) mmol/L, P=0.011). The change of 24 h UFC between the effective treatment group and ineffective group was statistically significant (P=0.020). The postoperative systolic blood pressure in the treated adenoma group was significantly lower than those of hyperplasia group (112±13) mmHg vs. (139±20) mmHg, P=0.026). Conclusions: For patients with CS-associated hypertension who are unwilling or unable to undergo surgical treatment, catheter-based adrenal ablation could improve the blood pressure and cortisol level. Catheter-based adrenal ablation could be a safe, effective, and minimally invasive therapy. However, our results still need to be validated in further large-scale studies.


Subject(s)
Male , Humans , Cushing Syndrome/complications , Hydrocortisone , Adrenal Gland Neoplasms/surgery , Feasibility Studies , Blood Glucose , Hyperplasia/complications , Hypertension/complications , Adenoma/complications , Body Weight , Catheters/adverse effects
15.
Zhonghua zhong liu za zhi ; (12): 1041-1050, 2023.
Article in Chinese | WPRIM | ID: wpr-1045833

ABSTRACT

Objective: To evaluate the participation rate and detection of colorectal neoplasms based on annual fecal immunochemical testing (FIT) for three consecutive years in a population-based colorectal cancer screening program in China. Methods: Based on a population-based colorectal cancer screening program conducted from May 2018 to May 2021 in 6 centers in China, 7 793 eligible participants aged 50-74 were included and offered free FIT and colonoscopy (for those who were FIT-positive on initial screening). At baseline, all participants were invited to receive FIT. In subsequent screening rounds, only FIT-positive participants who did not undergo colonoscopy or FIT-negative participants were invited to have repeated FIT screening. FIT-positive participants were recommended to undertake colonoscopy and pathological examination (if abnormalities were found during colonoscopy). An overall of three rounds of annual FIT screening were conducted. The primary outcomes of the study were the participation rate of FIT screening, the compliance rate of colonoscopy for FIT-positive participants, and the detection rate of colorectal neoplasms. Results: Among the 7 793 participants included in this study, 3 310 (42.5%) were male, with age of (60.50±6.49) years. The overall participation rates for the first, second and third round of FIT screening were 94.0%(7 327/7 793), 86.8% (6 048/6 968) and 91.3% (6 113/6 693), respectively. Overall, 7 742 out of 7 793 participants (99.3%) attended at least one round of screening, and 5 163 out of 7 793 participants (66.3%) attended all three rounds of screening. The positivity rate was significantly higher in the first (14.6%, 1 071/7 327) round compared with the second (5.6%, 3 41/6 048) and third (5.5%, 3 39/6 113) screening rounds (P<0.001). The overall compliance rates of colonoscopy examination among FIT-positive subjects were over 70% in three rounds, which were 76.3% (817/1 071), 75.7% (258/341) and 71.7% (243/339), respectively. In a multivariate logistic regression model considering factors including sex, education background, smoking, alcohol drinking, previous colonoscopy examination, colonic polyp history and family history of colorectal cancer among first-degree relatives, gender and smoking status were related factors affecting the participation rate of FIT screening, with higher rate in males and non-smokers. In addition, logistic regression analysis also found that age was negatively correlated with the compliance rate of colonoscopy in FIT positive patients. The detection rate of advanced tumors (colorectal cancer + advanced adenoma) declined from the first round to subsequent rounds [1st round: 1.15% (90/7 793); 2nd round: 0.57% (40/6 968); and 3rd round: 0.58% (39/6 693)], however, the positive predictive value for advanced neoplasms increased round by round, and was 11.02% in the first screening round, 15.50% in the second screening round, and 16.05 % in the third screening round. In each screening round, the detection rate for advanced neoplasms was higher in men than that in women, and increased with age. Conclusions: Annual repeated FIT screening has high acceptance and satisfying detection rates in the Chinese population. To optimize and improve the effectiveness of colorectal cancer screening, multi-round repeated FIT screening should be implemented while ensuring high participation rates.


Subject(s)
Humans , Male , Female , Early Detection of Cancer , Predictive Value of Tests , Colonoscopy , Mass Screening , Adenoma/diagnosis , Colorectal Neoplasms/pathology
16.
Beijing Da Xue Xue Bao ; (6): 1062-1067, 2023.
Article in Chinese | WPRIM | ID: wpr-1010169

ABSTRACT

OBJECTIVE@#To investigate the coagulation function indicators and identify influence factors of hypercoagulability in patients with adrenocorticotropic hormone (ACTH) independent Cushing syndrome (CS).@*METHODS@#In our retrospective study, the electronic medical records system of Peking University First Hospital was searched for the patients diagnosed with ACTH independent CS on discharge from January 2014 to June 2019. Nonfunctional adrenal adenoma patients were chosen as control group and matched 1 ∶1 by body mass index (BMI), gender, and discharge date. Clinical features and coagulation function indicators were compared between the two groups.@*RESULTS@#In the study, 171 patients were included in each group. Compared with control group, activated partial thromboplastin time (APTT), and prothrombin time (PT) in ACTH independent CS group were significantly lower [(29.22±3.39) s vs. (31.86±3.63) s, P < 0.001; (29.22±3.39) s vs. (31.86±3.63) s, P < 0.001], and both D-dimer and fibrin degradation products (FDP) levels were significantly higher (P < 0.05). Percentage of APTT levels under the lower limit of reference range in the CS patients was significantly higher than that in nonfunctional group (21.6% vs. 3.5%, P < 0.001). Percentage of D-dimer levels over the upper limit of reference range in the CS patients was significantly higher than that in nonfunctional group (13.5% vs. 6.6%, P=0.041). There were three patients with deep venous thrombosis and one patient with pulmonary embolism in CS group, however none was in control group. The area under curve (AUC) of serum cortisol rhythm (8:00, 16:00 and 24:00) levels was negatively associated with the levels of PT (r=-0.315, P < 0.001) and APTT (r=-0.410, P < 0.001), and positively associated with FDP (r=0.303, P < 0.001) and D-dimer levels (r=0.258, P < 0.001). There were no differences in coagulation function indicators among different histopathologic subgroups (adrenocortical adenoma, adrenocortical hyperplasia, oncocytic adenoma, adrenocortical carcinoma). With Logistic regression analysis, the AUC of cortisol and glycosylated hemoglobin A1c (HbA1c) levels were independent risk factors for hypercoagulability in the ACTH independent CS patients (P < 0.05).@*CONCLUSION@#ACTH independent CS patients were more likely in hypercoagulable state compared with nonfunctional adrenal adenoma, especially in ACTH independent CS patients with higher levels of cortisol AUC and HbA1c. These patients should be paid attention to for the hypercoagulability and thrombosis risk.


Subject(s)
Humans , Cushing Syndrome/complications , Adrenocortical Adenoma/complications , Adrenocorticotropic Hormone , Hydrocortisone , Retrospective Studies , Glycated Hemoglobin , Adrenal Cortex Neoplasms/diagnosis , Adenoma/diagnosis , Thrombophilia/complications
17.
Zhonghua Bing Li Xue Za Zhi ; (12): 1210-1215, 2023.
Article in Chinese | WPRIM | ID: wpr-1012395

ABSTRACT

Objective: To identify BRAF V600E mutations in adult Wilms tumor (WT) with overlapping histologic features of metanephric adenoma (MA) and to investigate the clinicopathological features of adult WT. Methods: The clinical features of adult WT diagnosed at the Fudan University Shanghai Cancer Center, Shanghai, China from 2012 to 2021 were reviewed. HE-stained slides of all cases were reviewed by 2 expert pathologists. Representative tissues were selected for BRAF V600E immunohistochemical (IHC) staining and gene sequencing. Results: In adult WT with MA-like areas (cohort Ⅰ, n=6), 5 of the 6 cases were composed of epithelial-predominant and were positive for WT-1 and CD56, respectively, and all were positive for CD57. All 6 cases revealed highly variable Ki-67 indices, ranging from 1% in some areas to 60% in others. 5 of the 6 cases harbored a BRAF V600E mutation. All cases in cohort I were followed up for 23 to 71 months, and all survived. In classical adult WT without MA-like areas cohort (cohort Ⅱ, n=13), all 7 cases with available material were negative for BRAF by IHC and none of them had any BRAF mutation. Conclusions: BRAF V600E mutations are frequently present in adult WT with overlapping morphologically features of MA, but not in those without. More importantly, adult WTs with overlapping histologic features of MA may be an intermediate entity between typical MA and WT that may have a favorable prognosis and possible therapeutic targets.


Subject(s)
Adult , Humans , Proto-Oncogene Proteins B-raf/genetics , China , Wilms Tumor/genetics , Kidney Neoplasms/pathology , Mutation , Adenoma/genetics , Biomarkers, Tumor/genetics
18.
Article in Chinese | WPRIM | ID: wpr-986800

ABSTRACT

Objective: To explore the utility of stool-based DNA test of methylated SDC2 (mSDC2) for colorectal cancer (CRC) screening in residents of Shipai Town, Dongguan City. Methods: This was a cross-sectional study. Using a cluster sampling method, residents of 18 villages in Shipai Town, Dongguan City were screened for CRC from May 2021 to February 2022. In this study, mSDC2 testing was employed as a preliminary screening method. Colonoscopy examination was recommended for individuals identified as high-risk based on the positive mSDC2 tests. The final screening results, including the rate of positive mSDC2 tests, the rate of colonoscopy compliance, the rate of lesions detection, and the cost-effectiveness of screening, were analyzed to explore the benefits of this screening strategy. Results: A total of 10 708 residents were enrolled and completed mSDC2 testing, giving a participation rate of 54.99% (10 708/19 474) and a pass rate of 97.87% (10 708/10 941). These individuals included 4 713 men (44.01%) and 5 995 women (55.99%) with a mean age of (54.52±9.64) years. The participants were allocated to four age groups (40-49, 50-59, 60-69, and 70-74 years), comprising 35.21%(3770/10 708), 36.25% (3882/10 708), 18.84% (2017/10 708), and 9.70% (1039/10 708) of all participants, respectively. mSDC2 testing was positive in 821/10 708 (7.67%) participants, 521 of whom underwent colonoscopy, resulting in a compliance rate of 63.46% (521/821). After eliminating of 8 individuals without pathology results, data from 513 individuals were finally analyzed. Colonoscopy detection rate differed significantly between age groups (χ2=23.155, P<0.001),ranging from a low of 60.74% in the 40-49 year age group to a high of 86.11% in the 70-74 year age group. Colonoscopies resulted in the diagnosis of 25 (4.87%) CRCs, 192 (37.43%) advanced adenomas, 67 (13.06%) early adenomas, 15 (2.92%) serrated polyps, and 86 (16.76%) non- adenomatous polyps. The 25 CRCs were Stage 0 in 14 (56.0%) individuals, stage I in 4 (16.0%), and Stage II in 7(28.0%). Thus, 18 of the detected CRCs were at an early stage. The early detection rate of CRCs and advanced adenomas was 96.77% (210/217). The rate of mSDC2 testing for all intestinal lesions was 75.05% (385/513). In particular, the financial benefit of this screening was 32.64 million yuan, and the benefit-cost ratio was 6.0. Conclusion: Screening for CRCs using stool-based mSDC2 testing combined with colonoscopy has a high lesion detection rate and a high cost-effectiveness ratio. This is a CRC screening strategy that deserves to be promoted in China.


Subject(s)
Male , Humans , Female , Adult , Middle Aged , Cross-Sectional Studies , Early Detection of Cancer/methods , Colorectal Neoplasms/pathology , Colonoscopy/methods , Mass Screening/methods , Adenoma/diagnosis , DNA , Syndecan-2/genetics
19.
Article in Chinese | WPRIM | ID: wpr-982745

ABSTRACT

〓 Objectives: To analyze the pathological and clinical features of nasal respiratory epithelial adenomatoid hamartoma(REAH), and summarize the diagnostic points, to improve the experience of diagnosis and treatment. Methods:The clinical data of 16 patients with REAH were analyzed retrospectively. The clinical manifestations, pathological features, imaging features, surgical treatment and prognosis were summarized. Results:16 cases of REAH were studied, 10 cases(62.50%) were associated with sinusitis, 1 case(6.25%) was associated with inverted papilloma, 1 case(6.25%) was associated with hemangioma. 5 cases(31.25%) had a history of nasal sinus surgery, including 1 case with 3 times of nasal sinus surgery, 1 case with 2 times of nasal sinus surgery, 3 cases with 1 time of nasal sinus surgery; 10 cases(62.50%) occurred in the bilateral olfactory cleft, 2 cases(12.50%) in the unilateral olfactory cleft, 3 cases(18.75%) in the unilateral middle turbinate, 1 case(6.25%) in the nasopharynx. All 16 patients were pathologically diagnosed as REAH. In the patients with lesions located in bilateral olfactory fissures, symmetrical widening of olfactory fissures and lateral displacement of middle turbinate were observed on preoperative sinus CT. The average width of bilateral olfactory fissures was (9.9±2.70) mm. The ratio of wide to narrow olfactory cleft was 1.21 ± 0.19. There was no significant difference in Lund-Mackay score between the two sides(P>0.05). All patients underwent surgery under general anesthesia and nasal endoscopy. The follow-up period ranged from 1 to 66 months, and no recurrence occurred. Conclusion:Preoperative diagnosis of REAH is facilitated by the combination of clinical manifestations and endoscopic and imaging features. Endoscopic complete resection can achieve a good therapeutic effect.


Subject(s)
Humans , Nasal Polyps/complications , Retrospective Studies , Paranasal Sinuses/pathology , Adenoma , Endoscopy/methods , Hamartoma/surgery
20.
Zhongguo Zhong Yao Za Zhi ; (24): 6269-6277, 2023.
Article in Chinese | WPRIM | ID: wpr-1008825

ABSTRACT

The Guidelines for prevention and treatment of colorectal adenoma with integrated Chinese and western medicine are put forward by Nanjing University of Chinese Medicine and approved by China Association of Chinese Medicine. According to the formulation processes and methods of relevant clinical practice guidelines, the experts in clinical medicine and methodology were organized to discuss the key problems to be addressed in the clinical prevention and treatment of colorectal adenoma(CRA) and provided answers following the evidence-based medicine method, so as to provide guidance for clinical decision-making. CRA is the major precancerous disease of colorectal cancer. Although the prevention and treatment with integrated Chinese and western medicine have been applied to the clinical practice of CRA, there is still a lack of high-quality guidelines. Four basic questions, 15 clinical questions, and 10 outcome indicators were determined by literature research and Delphi questionnaire. The relevant randomized controlled trial(RCT) was retrieved from CNKI, Wanfang, VIP, SinoMed, PubMed, EMbase, Cochrane Library, Web of Science, and 2 clinical trial registries, and finally several RCTs meeting the inclusion criteria were included. The data extracted from the RCT was imported into RevMan 5.3 for evidence synthesis, and the evidence was evaluated based on the Grading of Recommendations, Assessment, Development, and Evaluations(GRADE). The final recommendations were formed by the nominal group method based on the evidence summary table. The guidelines involve the diagnosis, screening, treatment with integrated Chinese and western medicine, prevention, and follow-up of colorectal adenoma, providing options for the clinical prevention and treatment of CRA.


Subject(s)
Humans , Adenoma/prevention & control , Colorectal Neoplasms/prevention & control , Drugs, Chinese Herbal/therapeutic use , Evidence-Based Medicine , Medicine, Chinese Traditional
SELECTION OF CITATIONS
SEARCH DETAIL